株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

眼科用治療薬の世界市場:成長動向と競争分析 (2018~2025年)

Global Ophthalmic Therapeutic Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

発行 QYResearch 商品コード 699000
出版日 ページ情報 英文 111 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
眼科用治療薬の世界市場:成長動向と競争分析 (2018~2025年) Global Ophthalmic Therapeutic Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
出版日: 2018年09月11日 ページ情報: 英文 111 Pages
概要

当レポートでは、世界の眼病治療用の点眼剤の市場について分析し、業界の基本構造や背景事情・最新情勢、全体的な市場規模の動向見通し、種類別・用途別および地域別の詳細動向、企業別の市場シェア構造、主要企業のプロファイル、今後の市場成長の可能性・方向性などを調査しております。

第1章 分析概要

  • 分析範囲
  • 分析対象メーカー
  • 市場分析:種類別
    • 世界の眼科用治療薬の市場規模・成長率:種類別
    • 抗炎症剤
    • 抗感染剤
    • 抗緑内障剤
  • 用途別の市場区分
    • 眼科用治療薬の市場シェア:用途別 (通算8年間分)
  • 分析対象
  • 分析期間

第2章 世界市場の成長動向

  • 市場規模の分析
    • 市場収益額 (金額ベース、通算13年間分)
    • 販売量 (数量ベース、通算13年間分)
  • 市場成長率:地域別
    • 販売量の増加率:地域別 (金額ベース、通算13年間分)
    • 市場収益額の成長率:地域別 (数量ベース、通算13年間分)
  • 産業動向
    • 市場の主な動向
    • 市場促進要因

第3章 企業別の市場シェア

  • 販売量:メーカー別
    • 販売量:メーカー別 (過去6年間分)
    • 販売量シェア:メーカー別 (過去6年間分)
  • 市場収益額:メーカー別
    • 市場収益額:メーカー別 (過去6年間分)
    • 市場収益額シェア:メーカー別 (過去6年間分)
    • 市場集中度 (上位5社分、HHI指数)
  • 眼科用治療薬の価格:メーカー別
  • 主要企業の製造拠点・販売地域
  • 主要企業の市場参入時期
  • 主要企業の主力製品
  • 企業合併・買収 (M&A)、事業拡張計画

第4章 種類別の市場規模

  • 販売量・市場収益額:種類別 (過去6年間分)
    • 抗炎症剤
    • 抗感染剤
    • 抗緑内障剤
  • 販売量シェア:種類別
  • 市場収益額シェア:種類別
  • 製品価格の動向:種類別

第5章 用途別の市場規模

  • 概要
  • 販売量:用途別

第6章 北米市場

  • 企業別の市場区分
  • 種類別の市場区分
  • 用途別の市場区分
  • 国別の市場区分:米国、カナダ、メキシコ

第7章 欧州市場

  • 国別の市場区分:ドイツ、フランス、英国、イタリア、ロシア

第8章 アジア太平洋地域市場

  • 国別の市場区分:中国、日本、韓国、インド、オーストラリア、インドネシア、マレーシア、フィリピン、タイ、ベトナム

第9章 中南米市場

  • 国別の市場区分:ブラジル

第10章 中東・アフリカ市場

  • 国別の市場区分:湾岸協力会議 (GCC) 諸国、エジプト、南アフリカ

第11章 企業プロファイル

  • Bayer
    • 主要データ
    • 企業概略・事業概要
    • 眼科用治療薬の販売量・市場収益額・市場シェア
    • 自動車用ミリ波レーダーの製品情報
    • 近年の主な動向
  • Pfizer
  • Novartis
  • ALLERGAN
  • Aerie Pharmaceuticals
  • Valeant Pharmaceuticals International
  • Genentech
  • Regeneron Pharmaceuticals
  • Shire
  • 参天製薬

第12章 バリューチェーン/販売チャネルの分析

  • バリューチェーン分析
  • 販売チャネル分析
    • 眼科用治療薬の販売チャネル
    • 眼科用治療薬の流通業者
  • 眼科用治療薬の需要家
  • 市場機会
  • 市場の課題
  • ポーターのファイブフォース分析
  • マクロ的指標
    • 主要国のGDP
    • 原材料の価格動向 (単位:米ドル)

第13章 市場予測

  • 眼科用治療薬の販売量・市場収益額の予測 (今後8年間分)
  • 販売量の予測:種類別
  • 販売量の予測:用途別
  • 市場予測:地域別
    • 販売量:地域別 (今後8年間分)
    • 市場収益額の予測:地域別 (今後8年間分)
  • 北米市場:国別の市場予測
    • 米国、カナダ、メキシコ
  • 欧州市場:国別の市場予測
    • ドイツ、フランス、英国、イタリア、ロシア
  • アジア太平洋地域:国別の市場予測
    • 中国、日本、韓国、インド、オーストリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム
  • 中南米市場:国別の市場予測
    • ブラジル
  • 中東・アフリカ市場:国別の市場予測
    • 湾岸協力会議 (GCC) 諸国、エジプト、南アフリカ

第14章 分析結果と結論

第15章 付録

図表

List of Tables and Figures

  • Figure Ophthalmic Therapeutic Drugs Product Picture
  • Table Ophthalmic Therapeutic Drugs Key Market Segments
  • Table Major Manufacturers Ophthalmic Therapeutic Drugs Covered in This Report
  • Table Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Shar by Type 2013-2025
  • Figure Anti-inflammatory Drugs Figures
  • Table Major Manufacturers of Anti-inflammatory Drugs
  • Figure Anti-infective Drugs Figures
  • Table Major Manufacturers of Anti-infective Drugs
  • Figure Anti-glaucoma Drugs Figures
  • Table Major Manufacturers of Anti-glaucoma Drugs
  • Figure Anti-allergy Drugs Figures
  • Table Major Manufacturers of Anti-allergy Drugs
  • Figure Anti-VEGF Agents Figures
  • Table Global Ophthalmic Therapeutic Drugs Market Share by Application 2018-2025 (K Units)
  • Figure Ophthalmic Therapeutic Drugs Report Years Considered
  • Figure Global Ophthalmic Therapeutic Drugs Market Size 2013-2025 (Million US$)
  • Figure Global Ophthalmic Therapeutic Drugs Sales 2013-2018 (K Units)
  • Table Global Ophthalmic Therapeutic Drugs Market Size by Regions 2013-2018 (K Units) & (Million US$)
  • Table Global Ophthalmic Therapeutic Drugs Sales by Regions 2013-2018 (K Units)
  • Table Global Ophthalmic Therapeutic Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Share by Regions in 2018
  • Table Global Ophthalmic Therapeutic Drugs Revenue by Regions 2013-2018 (Million US$)
  • Table Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Ophthalmic Therapeutic Drugs Sales by Manufacturers (2013-2018) (K Units)
  • Table Global Ophthalmic Therapeutic Drugs Sales Share by Manufacturers (2013-2018)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Share by Manufacturers in 2018
  • Table Ophthalmic Therapeutic Drugs Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers (2013-2018)
  • Figure Ophthalmic Therapeutic Drugs Value Share by Manufacturers in 2018
  • Table Global Ophthalmic Therapeutic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Ophthalmic Therapeutic Drugs Price (2013-2018) (USD/Unit)
  • Table Key Manufacturers Ophthalmic Therapeutic Drugs Plants/Factories Distribution
  • Table Key Manufacturers Ophthalmic Therapeutic Drugs Area Served
  • Table Date of Key Manufacturers Enter into Ophthalmic Therapeutic Drugs Market
  • Table Key Manufacturers Ophthalmic Therapeutic Drugs Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Anti-inflammatory Drugs Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Anti-infective Drugs Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Anti-glaucoma Drugs Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Ophthalmic Therapeutic Drugs Sales by Type (2013-2018) (K Units)
  • Table Global Ophthalmic Therapeutic Drugs Sales Share by Type (2013-2018)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Share by Type (2013-2018)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Share by Type in 2017
  • Table Global Ophthalmic Therapeutic Drugs Revenue by Type (2013-2018) (Million US$)
  • Table Global Ophthalmic Therapeutic Drugs Revenue Share by Type (2013-2018)
  • Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2013-2018)
  • Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type in 2017
  • Table Ophthalmic Therapeutic Drugs Price by Type 2013-2018 (USD/Unit)
  • Table Global Ophthalmic Therapeutic Drugs Sales by Application (2013-2018) (K Units)
  • Table Global Ophthalmic Therapeutic Drugs Sales Share by Application (2013-2018)
  • Figure Global Sales Ophthalmic Therapeutic Drugs Market Share by Application (2013-2018)
  • Figure Global Sales Ophthalmic Therapeutic Drugs Market Share by Application in 2017
  • Figure North America Ophthalmic Therapeutic Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure North America Ophthalmic Therapeutic Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Ophthalmic Therapeutic Drugs Sales by Company (2013-2018) (K Units)
  • Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Company (2013-2018)
  • Figure North America Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2018
  • Table North America Ophthalmic Therapeutic Drugs Sales by Type (2013-2018) (K Units)
  • Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Type (2013-2018)
  • Figure North America Ophthalmic Therapeutic Drugs Market Share by Type in 2018
  • Table North America Ophthalmic Therapeutic Drugs Sales by Application (2013-2018) (K Units)
  • Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Application (2013-2018)
  • Figure North America Ophthalmic Therapeutic Drugs Market Share by Application in 2018
  • Table North America Ophthalmic Therapeutic Drugs Sales by Countries (2013-2018) (K Units)
  • Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Ophthalmic Therapeutic Drugs Sales Market Share by Countries
  • Table North America Ophthalmic Therapeutic Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table North America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries
  • Figure United States Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Canada Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Mexico Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Europe Ophthalmic Therapeutic Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Europe Ophthalmic Therapeutic Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Ophthalmic Therapeutic Drugs Sales by Company (2013-2018) (K Units)
  • Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Company (2013-2018)
  • Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2018
  • Table Europe Ophthalmic Therapeutic Drugs Sales by Type (2013-2018) (K Units)
  • Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Ophthalmic Therapeutic Drugs Market Share by Type
  • Table Europe Ophthalmic Therapeutic Drugs Sales by Application (2013-2018) (K Units)
  • Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Ophthalmic Therapeutic Drugs Market Share by Application
  • Table Europe Ophthalmic Therapeutic Drugs Sales by Countries (2013-2018) (K Units)
  • Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Ophthalmic Therapeutic Drugs Sales Market Share by Countries
  • Table Europe Ophthalmic Therapeutic Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Countries in 2018
  • Figure Germany Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure France Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure UK Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Italy Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Russia Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific Ophthalmic Therapeutic Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Asia Pacific Ophthalmic Therapeutic Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Company (2013-2018) (K Units)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2018
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Type (2013-2018) (K Units)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Ophthalmic Therapeutic Drugs Market Share by Type in 2018
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Application (2013-2018) (K Units)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Ophthalmic Therapeutic Drugs Market Share by Application in 2018
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Countries (2013-2018) (K Units)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Countries
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Ophthalmic Therapeutic Drugs Revenue Market Share by Countries
  • Figure China Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure China Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Japan Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Korea Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure India Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Australia Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Indonesia Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Malaysia Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Philippines Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Thailand Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Vietnam Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Ophthalmic Therapeutic Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Central & South America Ophthalmic Therapeutic Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales by Company (2013-2018) (K Units)
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Company (2013-2018)
  • Figure Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2018
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales by Type (2013-2018) (K Units)
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Type (2013-2018)
  • Figure Central & South America Ophthalmic Therapeutic Drugs Market Share by Type in 2018
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales by Application (2013-2018) (K Units)
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Application (2013-2018)
  • Figure Central & South America Ophthalmic Therapeutic Drugs Market Share by Application in 2018
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales by Countries (2013-2018) (K Units)
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Countries in 2018
  • Table Central & South America Ophthalmic Therapeutic Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries in 2018
  • Figure Brazil Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Brazil Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa Ophthalmic Therapeutic Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Type (2013-2018) (K Units)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Market Share by Type
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Application (2013-2018) (K Units)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Market Share by Application
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Countries (2013-2018) (K Units)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Countries
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Countries
  • Figure GCC Countries Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure GCC Countries Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure Egypt Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Egypt Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure South Africa Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure South Africa Ophthalmic Therapeutic Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Table Bayer Company Details
  • Table Bayer Description and Business Overview
  • Table Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Bayer Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Bayer Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Bayer Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Description and Business Overview
  • Table Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Pfizer Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Pfizer Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Pfizer Recent Development
  • Table Novartis Company Details
  • Table Novartis Description and Business Overview
  • Table Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Novartis Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Novartis Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Novartis Recent Development
  • Table ALLERGAN Company Details
  • Table ALLERGAN Description and Business Overview
  • Table ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table ALLERGAN Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table ALLERGAN Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table ALLERGAN Recent Development
  • Table Aerie Pharmaceuticals Company Details
  • Table Aerie Pharmaceuticals Description and Business Overview
  • Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Aerie Pharmaceuticals Recent Development
  • Table Valeant Pharmaceuticals International Company Details
  • Table Valeant Pharmaceuticals International Description and Business Overview
  • Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Valeant Pharmaceuticals International Recent Development
  • Table Genentech Company Details
  • Table Genentech Description and Business Overview
  • Table Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Genentech Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Genentech Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Genentech Recent Development
  • Table Regeneron Pharmaceuticals Company Details
  • Table Regeneron Pharmaceuticals Description and Business Overview
  • Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Regeneron Pharmaceuticals Recent Development
  • Table Shire Company Details
  • Table Shire Description and Business Overview
  • Table Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Shire Ophthalmic Therapeutic Drugs Sales Growth Rate (2013-2018)
  • Table Shire Ophthalmic Therapeutic Drugs Sales Market Share in Global Market
  • Table Shire Recent Development
  • Table Santen Pharmaceutical Company Details
  • Table Santen Pharmaceutical Description and Business Overview
  • Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Ophthalmic Therapeutic Drugs Value Chain
  • Table Ophthalmic Therapeutic Drugs Distributors List
  • Table Ophthalmic Therapeutic Drugs Customers List
  • Table Global Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Global Ophthalmic Therapeutic Drugs Revenue Forecast 2018-2025 (Million US$)
  • Table Global Ophthalmic Therapeutic Drugs Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Type 2018-2025
  • Table Global Ophthalmic Therapeutic Drugs Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Application 2018-2025
  • Table Global Ophthalmic Therapeutic Drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Global Ophthalmic Therapeutic Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Ophthalmic Therapeutic Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Ophthalmic Therapeutic Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table North America Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table North America Ophthalmic Therapeutic Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Canada Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure MexicoOphthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Table Europe Ophthalmic Therapeutic Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Europe Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Ophthalmic Therapeutic Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure France Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure UK Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Italy Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Russia Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Japan Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Korea Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure India Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Australia Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Indonesia Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Thailand Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Malaysia Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Philippines Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Vietnam Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Ophthalmic Therapeutic Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Ophthalmic Therapeutic Drugs Sales Forecast 2018-2025 (K Units)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units)
  • Figure Egypt Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units)
  • Figure South Africa Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
目次

This study researches the market size of Ophthalmic Therapeutic Drugs, presents the global Ophthalmic Therapeutic Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Ophthalmic Therapeutic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Ophthalmic Therapeutic Drugs for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2018, the global Ophthalmic Therapeutic Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Ophthalmic Therapeutic Drugs.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Bayer
  • Pfizer
  • Novartis
  • ALLERGAN
  • Aerie Pharmaceuticals
  • Valeant Pharmaceuticals International
  • Genentech
  • Regeneron Pharmaceuticals
  • Shire
  • Santen Pharmaceutical

Market Segment by Product Type

  • Anti-inflammatory Drugs
  • Anti-infective Drugs
  • Anti-glaucoma Drugs
  • Anti-allergy Drugs
  • Anti-VEGF Agents
  • Others

Market Segment by Application

  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies & Drug Stores

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Ophthalmic Therapeutic Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Ophthalmic Therapeutic Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ophthalmic Therapeutic Drugs are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
    • 1.3.1. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type
    • 1.3.2. Anti-inflammatory Drugs
    • 1.3.3. Anti-infective Drugs
    • 1.3.4. Anti-glaucoma Drugs
  • 1.4. Market Segment by Application
    • 1.4.1. Global Ophthalmic Therapeutic Drugs Market Share by Application (2018-2025)
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Ophthalmic Therapeutic Drugs Market Size
    • 2.1.1. Global Ophthalmic Therapeutic Drugs Revenue 2013-2025
    • 2.1.2. Global Ophthalmic Therapeutic Drugs Sales 2013-2025
  • 2.2. Ophthalmic Therapeutic Drugs Growth Rate by Regions
    • 2.2.1. Global Ophthalmic Therapeutic Drugs Sales by Regions 2013-2018
    • 2.2.2. Global Ophthalmic Therapeutic Drugs Revenue by Regions 2013-2018
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Ophthalmic Therapeutic Drugs Sales by Manufacturers
    • 3.1.1. Ophthalmic Therapeutic Drugs Sales by Manufacturers 2013-2018
    • 3.1.2. Ophthalmic Therapeutic Drugs Sales Market Share by Manufacturers 2013-2018
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Ophthalmic Therapeutic Drugs Revenue by Manufacturers (2013-2018)
    • 3.2.2. Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3. Ophthalmic Therapeutic Drugs Price by Manufacturers
  • 3.4. Key Manufacturers Ophthalmic Therapeutic Drugs Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Ophthalmic Therapeutic Drugs Market
  • 3.6. Key Manufacturers Ophthalmic Therapeutic Drugs Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Sales and Revenue for Each Type
    • 4.1.1. Anti-inflammatory Drugs Sales and Revenue (2013-2018)
    • 4.1.2. Anti-infective Drugs Sales and Revenue (2013-2018)
    • 4.1.3. Anti-glaucoma Drugs Sales and Revenue (2013-2018)
  • 4.2. Global Ophthalmic Therapeutic Drugs Sales Market Share by Type
  • 4.3. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type
  • 4.4. Ophthalmic Therapeutic Drugs Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Ophthalmic Therapeutic Drugs Sales by Application

6. North America

  • 6.1. North America Ophthalmic Therapeutic Drugs Breakdown Data by Company
  • 6.2. North America Ophthalmic Therapeutic Drugs Breakdown Data by Type
  • 6.3. North America Ophthalmic Therapeutic Drugs Breakdown Data by Application
  • 6.4. North America Ophthalmic Therapeutic Drugs Breakdown Data by Countries
    • 6.4.1. North America Ophthalmic Therapeutic Drugs Sales by Countries
    • 6.4.2. North America Ophthalmic Therapeutic Drugs Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Ophthalmic Therapeutic Drugs Breakdown Data by Company
  • 7.2. Europe Ophthalmic Therapeutic Drugs Breakdown Data by Type
  • 7.3. Europe Ophthalmic Therapeutic Drugs Breakdown Data by Application
  • 7.4. Europe Ophthalmic Therapeutic Drugs Breakdown Data by Countries
    • 7.4.1. Europe Ophthalmic Therapeutic Drugs Sales by Countries
    • 7.4.2. Europe Ophthalmic Therapeutic Drugs Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Ophthalmic Therapeutic Drugs Breakdown Data by Company
  • 8.2. Asia Pacific Ophthalmic Therapeutic Drugs Breakdown Data by Type
  • 8.3. Asia Pacific Ophthalmic Therapeutic Drugs Breakdown Data by Application
  • 8.4. Asia Pacific Ophthalmic Therapeutic Drugs Breakdown Data by Countries
    • 8.4.1. Asia Pacific Ophthalmic Therapeutic Drugs Sales by Countries
    • 8.4.2. Asia Pacific Ophthalmic Therapeutic Drugs Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Ophthalmic Therapeutic Drugs Breakdown Data by Company
  • 9.2. Central & South America Ophthalmic Therapeutic Drugs Breakdown Data by Type
  • 9.3. Central & South America Ophthalmic Therapeutic Drugs Breakdown Data by Application
  • 9.4. Central & South America Ophthalmic Therapeutic Drugs Breakdown Data by Countries
    • 9.4.1. Central & South America Ophthalmic Therapeutic Drugs Sales by Countries
    • 9.4.2. Central & South America Ophthalmic Therapeutic Drugs Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Ophthalmic Therapeutic Drugs Breakdown Data by Type
  • 10.2. Middle East and Africa Ophthalmic Therapeutic Drugs Breakdown Data by Application
  • 10.3. Middle East and Africa Ophthalmic Therapeutic Drugs Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Countries
    • 10.3.2. Middle East and Africa Ophthalmic Therapeutic Drugs Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. Bayer
    • 11.1.1. Bayer Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.1.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.1.5. Bayer Recent Development
  • 11.2. Pfizer
    • 11.2.1. Pfizer Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.2.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.2.5. Pfizer Recent Development
  • 11.3. Novartis
    • 11.3.1. Novartis Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.3.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.3.5. Novartis Recent Development
  • 11.4. ALLERGAN
    • 11.4.1. ALLERGAN Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.4.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.4.5. ALLERGAN Recent Development
  • 11.5. Aerie Pharmaceuticals
    • 11.5.1. Aerie Pharmaceuticals Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.5.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.5.5. Aerie Pharmaceuticals Recent Development
  • 11.6. Valeant Pharmaceuticals International
    • 11.6.1. Valeant Pharmaceuticals International Company Details
    • 11.6.2. Company Description and Business Overview
    • 11.6.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.6.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.6.5. Valeant Pharmaceuticals International Recent Development
  • 11.7. Genentech
    • 11.7.1. Genentech Company Details
    • 11.7.2. Company Description and Business Overview
    • 11.7.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.7.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.7.5. Genentech Recent Development
  • 11.8. Regeneron Pharmaceuticals
    • 11.8.1. Regeneron Pharmaceuticals Company Details
    • 11.8.2. Company Description and Business Overview
    • 11.8.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.8.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.8.5. Regeneron Pharmaceuticals Recent Development
  • 11.9. Shire
    • 11.9.1. Shire Company Details
    • 11.9.2. Company Description and Business Overview
    • 11.9.3. Sales, Revenue and Market Share of Ophthalmic Therapeutic Drugs
    • 11.9.4. Ophthalmic Therapeutic Drugs Product Introduction
    • 11.9.5. Shire Recent Development
  • 11.10. Santen Pharmaceutical
    • 11.10.1. Santen Pharmaceutical Company Details
    • 11.10.2. Company Description and Business Overview

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Ophthalmic Therapeutic Drugs Sales Channels
    • 12.2.2. Ophthalmic Therapeutic Drugs Distributors
  • 12.3. Ophthalmic Therapeutic Drugs Customers

13. Market Forecast

  • 13.1. Global Ophthalmic Therapeutic Drugs Sales and Revenue Forecast 2018-2025
  • 13.2. Global Ophthalmic Therapeutic Drugs Sales Forecast by Type
  • 13.3. Global Ophthalmic Therapeutic Drugs Sales Forecast by Application
  • 13.4. Ophthalmic Therapeutic Drugs Forecast by Regions
    • 13.4.1. Global Ophthalmic Therapeutic Drugs Sales Forecast by Regions 2018-2025
    • 13.4.2. Global Ophthalmic Therapeutic Drugs Revenue Forecast by Regions 2018-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Ophthalmic Therapeutic Drugs Forecast by Countries 2018-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Ophthalmic Therapeutic Drugs Forecast by Countries 2018-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Ophthalmic Therapeutic Drugs Sales Forecast by Countries 2018-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Ophthalmic Therapeutic Drugs Sales Forecast by Countries 2018-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Ophthalmic Therapeutic Drugs Sales Forecast by Countries 2018-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer
Back to Top